SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-005931
Filing Date
2022-08-12
Accepted
2022-08-12 16:46:20
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm   iXBRL 10-Q 890614
2 CERTIFICATION celz_ex311.htm EX-31.1 10110
3 CERTIFICATION celz_ex312.htm EX-31.2 9967
4 CERTIFICATION celz_ex321.htm EX-32.1 3947
5 CERTIFICATION celz_ex322.htm EX-32.2 3958
11 celz_10qimg1.jpg GRAPHIC 21751
  Complete submission text file 0001477932-22-005931.txt   3564074

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celz-20220630.xsd EX-101.SCH 45985
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20220630_lab.xml EX-101.LAB 241307
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20220630_cal.xml EX-101.CAL 36312
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20220630_pre.xml EX-101.PRE 194504
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20220630_def.xml EX-101.DEF 114691
43 EXTRACTED XBRL INSTANCE DOCUMENT celz_10q_htm.xml XML 381237
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

IRS No.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41120 | Film No.: 221160829
SIC: 2836 Biological Products, (No Diagnostic Substances)